Developer docs
API playgroundTry for free, no card

Search company profiles

BioMelbourne Network

Full company profile

uuid0005nnd

Namestring
BioMelbourne Network
Legal namestring
BioMelbourne Network
Company typeenum
Private
Founded yearint
2001
Descriptiontext

BioMelbourne Network is an industry-led, not-for-profit membership association established in February 2001 by the Committee for Melbourne and incorporated on 1 July 2003. It operates as Victoria's peak body for the health technologies sector, representing more than 200 member organisations and approximately 6,000 professionals across biotechnology, medical technology, digital health, pharmaceuticals, and adjacent research and service industries. The organisation was founded in response to a Boston Consulting Group report identifying an expertise gap in Victoria's biotechnology sector, received a three-year Victorian Government establishment grant in late 2002, and has been financially independent since 2005, funded by membership fees and event activity.

The association's product and service portfolio spans a tiered membership programme (Corporate A$5,340, SME A$3,170, SME-Micro A$1,935, Professional A$1,580, Entrepreneur A$695, and Director A$152 per annum), signature events such as BioSymposiums and the annual Connecting Women Lunch (nearly 700 attendees), the Women in Leadership Awards (now in its 11th year), and a set of digital ecosystem platforms. These platforms include Wilam (an online health technologies community with 7,000+ professionals), BioResource Hub (on-demand learning content), Careers Hub (industry job board), and the Australian Medtech Manufacturing Alliance (AMMA). Content channels include the fortnightly 'In the Loop' newsletter (7,000+ subscribers), the BioMelbourne Network Podcast on Spotify and Apple, and a 16,000+ LinkedIn following.

Revenue is generated primarily through recurring annual membership subscriptions and event-driven income from registration fees and sponsorship (e.g., CSL Behring as major sponsor of Connecting Women Lunch, IQVIA Biotech as Thought Leader Partner for clinical trials BioSymposiums, RMIT and FB Rice for biosensing BioSymposiums). Two non-recurring LaunchVic grants (A$97,000 in September 2017 and A$114,000 in October 2018) supplemented early operating income. The organisation is governed by a Board of Directors, runs with a small core team of 4–10 staff based at Level 6, HWT Tower, 40 City Road, Southbank, Melbourne, and is currently led by Interim CEO Michelle Gallaher. Strategic activity includes international trade missions to Singapore and Asia-Pacific and joint advocacy with eight other Australian peak bodies on R&D Tax Incentive and capital gains tax reform.

Short descriptiontext

BioMelbourne Network is a Victorian not-for-profit industry association, founded in 2001, that represents 200+ health technology member organisations and 6,000+ professionals across biotech, medtech, digital health, research, and government through tiered membership, events, and digital platforms.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMelbourne, Australia
HQ citystring
Melbourne
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
health technology membership, biotech industry association, medtech networking events, life sciences advocacy, biotech industry network
Industry1 code
PRIMARYTHAHAJAB
Life Sciences & Biotechnology Congresses
NAICS code1 code
  • Religious, Grantmaking, Civic, Professional, and Similar Organizations813
SIC code1 code
  • Services-Membership Organizations8600
Product category
Health Technology Industry Association
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Membership Fees
TypeSubscription Recurring
Description

Annual membership fees covering all employees within member organisations. Tiered pricing based on organisation size and type, from startups to large multinationals and universities.

biomelbourne.org
2Event Registration Fees
TypeSubscription Recurring
Description

Discounted member registration to all BioMelbourne Network events (in person and online), with non-member rates also available.

3Event Sponsorship
TypeProfessional Services
Description

Event hosting and sponsorship opportunities tailored to members' interests and budget.

biomelbourne.org
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details6 tiers
1Corporate Membership for mid-to-large Australian enterprise and multinationals, universities, independent medical research institutes, government agencies and parent companies
ModelSubscriptionBilling cadenceAnnual
Notes

$5,340 per annum excl. GST

2SME Membership for biotechnology and medical technology companies, SMEs, ASX listed companies with 100 or fewer employees
ModelSubscriptionBilling cadenceAnnual
Notes

$3,170 per annum excl. GST

3SME-Micro Membership for established small/micro businesses employing 5 or fewer people
ModelSubscriptionBilling cadenceAnnual
Notes

$1,935 per annum excl. GST

4Professional Membership for Sole Traders and independent freelance consultants supporting the sector
ModelSubscriptionBilling cadenceAnnual
Notes

$1,580 per annum excl. GST

5Entrepreneur Membership for startup companies developing biotech, medtech, digital and healthcare products in pre-seed to seed stage, strictly pre-revenue
ModelSubscriptionBilling cadenceAnnual
Notes

$695 per annum excl. GST (12 months only)

6Director Professional Membership for Sole Traders actively serving on the BioMelbourne Network Board
ModelSubscriptionBilling cadenceAnnual
Notes

$152 per annum excl. GST

GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

BioMelbourne Network is a not-for-profit, industry-led membership association that connects biotechnology, medical technology, and health innovation organisations in Victoria, Australia. It sells tiered annual memberships and delivers networking events, advocacy, and online community platforms (Wilam, BioResource Hub, Careers Hub) that foster collaboration, commercialisation, and policy engagement across the state's health technology ecosystem.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Represents 200+ member organisations and 6,000+ professionals from local, national and international companies
+4 more records
Product overview1 text field

BioMelbourne Network is an industry-led membership association for organizations engaged in biotechnology, medical technology, and health innovation in Victoria, Australia. Rather than a unified software product, it offers a portfolio of membership services, events programs, and online platforms. Membership programs provide networking, connections, and strategic updates across multiple tiers. Signature events include BioSymposium (sector conferences on topics like biosensing and clinical trials), the annual Connecting Women Lunch, and Women in Leadership Awards. Online platforms comprise Wilam (professional networking platform with 7,000+ members), BioResource Hub (on-demand learning), and Careers Hub (job board). Content services include a fortnightly 'In The Loop' newsletter (7,000+ subscribers) and podcast series. Trade missions connect Victorian companies with international markets. The organization also conducts advocacy and policy initiatives, including research publications like clinical trials white papers.

Product and service4 records
1Membership Programs
CategoryMembership Association Service
Description

Tiered annual industry membership for organisations engaged in biotechnology, medical technology, and health innovation in Victoria. Six tiers (Corporate $5,340, SME $3,170, SME-Micro $1,935, Professional $1,580, Entrepreneur $695, Director Professional $152) cover all employees within a member organisation and unlock networking, events, advocacy, and platform access.

2BioSymposium Events
CategoryIndustry Conference Series
Description

Signature paid symposium events that convene 100-150+ attendees to explore focused health technology topics such as 'Next-gen Biosensing' and 'Modernising clinical trials'. Members register at discounted rates; non-members pay higher rates. Sponsorship tiers include Major Sponsor, Thought Leader Partner, and Supporting Sponsor.

3Connecting Women Lunch
CategoryIndustry Networking Event
Description

Annual ticketed networking lunch celebrating women in health technologies, featuring keynote speakers, panel discussions, and recognition of sector achievements. Attracts nearly 700 attendees; sponsored by partners including CSL Behring.

4Wilam Community Platform
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
Strategic tierFoundingTypeStrategic or Co-development PartnerAnnounced on2001-02-01
Description

Established BioMelbourne Network in February 2001 following a Boston Consulting Group report on the Victorian biotechnology industry. Committee for Melbourne and BioMelbourne Network were successful in securing a three-year establishment grant from the State Government of Victoria in late 2002.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint advocacy partner on R&D Tax Incentive changes, representing Australia's biotech, medtech and health technology sector. Co-signatory on joint letters to Treasurer Jim Chalmers alongside seven other peak bodies.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Nine peak health and medical technology industry bodies united in opposition to proposed R&D Tax Incentive changes and capital gains tax reforms, sending joint letter to Treasurer Jim Chalmers.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Key government partner supporting BioMelbourne Network initiatives including BioSymposiums as Premier Sponsor, establishment grant in 2002, and ongoing sector development programs.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Major sponsor of BioSymposium 'Next-gen Biosensing' and collaborator on biosensing research translation initiatives.

Strategic tierMajorTypeGTM or Marketing Partner
Description

Major sponsor of BioSymposium 'Next-gen Biosensing'. Intellectual property consultancy supporting the health technology ecosystem.

Strategic tierSupportingTypeGTM or Marketing Partner
Description

Supporting sponsor of BioSymposium 'Next-gen Biosensing' and contributor to regulatory and clinical trials discussions.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Thought Leader Partner for BioSymposium 'Modernising clinical trials', bringing expertise in clinical trial design and execution.

Strategic tierMajorTypeGTM or Marketing Partner
Description

Major Sponsor for 'Modernising clinical trials' BioSymposium, supporting decentralised clinical trial discussions.

Strategic tierSupportingTypeGTM or Marketing Partner
Description

Supporting sponsor for clinical trials BioSymposium, providing insurance expertise for clinical research sector.

Strategic tierMajorTypeGTM or Marketing Partner
Description

Major sponsor of the 2026 Connecting Women Lunch. CSL has been a longstanding supporter of the event with video presentations.

12Global Victoria
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Government partner for trade missions to Singapore 2022, connecting Victorian health and medtech companies with international markets.

biomelbourne.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner for Singapore trade mission, providing networking events and investment facilitation for Victorian companies.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

International medtech accelerators and government partners collaborating on Singapore trade mission program.

15Wilam
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Online health technologies platform operated by BioMelbourne Network serving 7,000+ professionals with networking and resource capabilities.

biomelbourne.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
TypeDirect peer
Description

Australian industry body representing the in-vitro diagnostics and pathology technology sector. Directly comparable as a membership-based industry association representing health technology manufacturers and service providers, and a joint advocacy partner on R&D Tax Incentive issues.

TypeRegional player
Description

London-based life sciences cluster organisation supporting health technology and medtech companies in the greater London region. Comparable as a cluster-based industry body with a similar mission of connecting companies, research, and capital in a defined geographic health tech ecosystem, but operating in a different geography.

TypeDirect peer
Description

Australian Government-funded MedTech and Pharma Growth Centre, operating as an industry connector for the sector. Directly comparable as a peak body driving collaboration, events, and policy advocacy across Australia's medical technology and pharmaceutical sectors, and a co-signatory with BioMelbourne on national policy submissions.

TypeBroad incumbent
Description

Massachusetts' state-level biotechnology industry association, one of the largest and most established US life sciences industry bodies. Comparable as a broader incumbent offering a more comprehensive suite of member services, policy advocacy, and events, and serving as a benchmark model for the kind of regional life sciences association BioMelbourne aspires to be.

TypeRegional player
Description

Western Australia's peak industry body for the life sciences sector. Comparable to BioMelbourne Network as a state-level Australian membership association for health technologies, but operating in a different geography (WA) and not directly competing for Victorian members.

TypeDirect peer
Description

Australia's peak industry body for the clinical research, pharmaceutical, and medical device sectors. Directly comparable as a membership association providing professional development, advocacy, and sector events for organisations across the health technology value chain, and a fellow co-signatory on BioMelbourne's policy submissions.

TypeDirect peer
Description

Australia's national biotechnology industry association. Directly comparable as a membership-based industry body serving biotech, medtech, and health tech companies across Australia, and BioMelbourne's principal co-advocacy partner on R&D Tax Incentive issues.

TypeRegional player
Description

Queensland's peak industry body for life sciences and health technologies. Closely comparable to BioMelbourne Network as a state-level membership association, but operating in a different Australian state and therefore not in direct competition for Victorian members.

TypeRegional player
Description

New South Wales' industry association for the biotechnology and life sciences sector. Comparable as a state-level Australian membership body serving biotech and health tech organisations, but focused on NSW-based members and therefore a regional rather than direct competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BioMelbourne Network

Health Technology Industry Associationbiomelbourne.org

BioMelbourne Network is a Victorian not-for-profit industry association, founded in 2001, that represents 200+ health technology member organisations and 6,000+ professionals across biotech, medtech, digital health, research, and government through tiered membership, events, and digital platforms.

What BioMelbourne Network does

BioMelbourne Network is an industry-led, not-for-profit membership association established in February 2001 by the Committee for Melbourne and incorporated on 1 July 2003. It operates as Victoria's peak body for the health technologies sector, representing more than 200 member organisations and approximately 6,000 professionals across biotechnology, medical technology, digital health, pharmaceuticals, and adjacent research and service industries. The organisation was founded in response to a Boston Consulting Group report identifying an expertise gap in Victoria's biotechnology sector, received a three-year Victorian Government establishment grant in late 2002, and has been financially independent since 2005, funded by membership fees and event activity.

The association's product and service portfolio spans a tiered membership programme (Corporate A$5,340, SME A$3,170, SME-Micro A$1,935, Professional A$1,580, Entrepreneur A$695, and Director A$152 per annum), signature events such as BioSymposiums and the annual Connecting Women Lunch (nearly 700 attendees), the Women in Leadership Awards (now in its 11th year), and a set of digital ecosystem platforms. These platforms include Wilam (an online health technologies community with 7,000+ professionals), BioResource Hub (on-demand learning content), Careers Hub (industry job board), and the Australian Medtech Manufacturing Alliance (AMMA). Content channels include the fortnightly 'In the Loop' newsletter (7,000+ subscribers), the BioMelbourne Network Podcast on Spotify and Apple, and a 16,000+ LinkedIn following.

Revenue is generated primarily through recurring annual membership subscriptions and event-driven income from registration fees and sponsorship (e.g., CSL Behring as major sponsor of Connecting Women Lunch, IQVIA Biotech as Thought Leader Partner for clinical trials BioSymposiums, RMIT and FB Rice for biosensing BioSymposiums). Two non-recurring LaunchVic grants (A$97,000 in September 2017 and A$114,000 in October 2018) supplemented early operating income. The organisation is governed by a Board of Directors, runs with a small core team of 4–10 staff based at Level 6, HWT Tower, 40 City Road, Southbank, Melbourne, and is currently led by Interim CEO Michelle Gallaher. Strategic activity includes international trade missions to Singapore and Asia-Pacific and joint advocacy with eight other Australian peak bodies on R&D Tax Incentive and capital gains tax reform.

BioMelbourne Network firmographics

Firmographics
Name
BioMelbourne Network
Legal name
BioMelbourne Network
Website
https://biomelbourne.org
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
11–50 employees
Short description
BioMelbourne Network is a Victorian not-for-profit industry association, founded in 2001, that represents 200+ health technology member organisations and 6,000+ professionals across biotech, medtech, digital health, research, and government through tiered membership, events, and digital platforms.
Ownership category
akta.pro rank

BioMelbourne Network industry classification

Industry
Product category
Health Technology Industry Association
NAICS
Religious, Grantmaking, Civic, Professional, and Similar Organizations (813)
SIC
Services-Membership Organizations (8600)
akta.pro industry
PRIMARYTHAHAJAB
Life Sciences & Biotechnology Congresses

Keywords

  • Health technology membership
  • Biotech industry association
  • Medtech networking events
  • Life sciences advocacy
  • Biotech industry network

Where BioMelbourne Network is headquartered

Location

Headquarters

HQ city
Melbourne
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

BioMelbourne Network business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Membership Fees: Annual membership fees covering all employees within member organisations. Tiered pricing based on organisation size and type, from startups to large multinationals and universities.
  2. Event Registration Fees: Discounted member registration to all BioMelbourne Network events (in person and online), with non-member rates also available.
  3. Event Sponsorship: Event hosting and sponsorship opportunities tailored to members' interests and budget.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualCorporate Membership for mid-to-large Australian enterprise and multinationals, universities, independent medical research institutes, government agencies and parent companies
SubscriptionAnnualSME Membership for biotechnology and medical technology companies, SMEs, ASX listed companies with 100 or fewer employees
SubscriptionAnnualSME-Micro Membership for established small/micro businesses employing 5 or fewer people
SubscriptionAnnualProfessional Membership for Sole Traders and independent freelance consultants supporting the sector
SubscriptionAnnualEntrepreneur Membership for startup companies developing biotech, medtech, digital and healthcare products in pre-seed to seed stage, strictly pre-revenue
SubscriptionAnnualDirector Professional Membership for Sole Traders actively serving on the BioMelbourne Network Board

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

BioMelbourne Network product offering

Product offering

Core offering

BioMelbourne Network is a not-for-profit, industry-led membership association that connects biotechnology, medical technology, and health innovation organisations in Victoria, Australia. It sells tiered annual memberships and delivers networking events, advocacy, and online community platforms (Wilam, BioResource Hub, Careers Hub) that foster collaboration, commercialisation, and policy engagement across the state's health technology ecosystem.

Product overview

BioMelbourne Network is an industry-led membership association for organizations engaged in biotechnology, medical technology, and health innovation in Victoria, Australia. Rather than a unified software product, it offers a portfolio of membership services, events programs, and online platforms. Membership programs provide networking, connections, and strategic updates across multiple tiers. Signature events include BioSymposium (sector conferences on topics like biosensing and clinical trials), the annual Connecting Women Lunch, and Women in Leadership Awards. Online platforms comprise Wilam (professional networking platform with 7,000+ members), BioResource Hub (on-demand learning), and Careers Hub (job board). Content services include a fortnightly 'In The Loop' newsletter (7,000+ subscribers) and podcast series. Trade missions connect Victorian companies with international markets. The organization also conducts advocacy and policy initiatives, including research publications like clinical trials white papers.

Differentiator

Problem solved

Functional benefit

Products and services

  • Membership Programs Tiered annual industry membership for organisations engaged in biotechnology, medical technology, and health innovation in Victoria. Six tiers (Corporate $5,340, SME $3,170, SME-Micro $1,935, Professional $1,580, Entrepreneur $695, Director Professional $152) cover all employees within a member organisation and unlock networking, events, advocacy, and platform access.
  • BioSymposium Events Signature paid symposium events that convene 100-150+ attendees to explore focused health technology topics such as 'Next-gen Biosensing' and 'Modernising clinical trials'. Members register at discounted rates; non-members pay higher rates. Sponsorship tiers include Major Sponsor, Thought Leader Partner, and Supporting Sponsor.
  • Connecting Women Lunch Annual ticketed networking lunch celebrating women in health technologies, featuring keynote speakers, panel discussions, and recognition of sector achievements. Attracts nearly 700 attendees; sponsored by partners including CSL Behring.
  • Wilam Community Platform

Quantifiable outcome

  • Represents 200+ member organisations and 6,000+ professionals from local, national and international companies
  • +4 more outcomes

Companies that use BioMelbourne Network

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles5 records

BioMelbourne Network technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

BioMelbourne Network partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered founding, core, major, supporting and minor.

  • Committee for MelbournefoundingStrategic or Co-development Partner · 1 February 2001Established BioMelbourne Network in February 2001 following a Boston Consulting Group report on the Victorian biotechnology industry. Committee for Melbourne and BioMelbourne Network were successful in securing a three-year establishment grant from the State Government of Victoria in late 2002.
  • AusBiotechcoreStrategic or Co-development PartnerJoint advocacy partner on R&D Tax Incentive changes, representing Australia's biotech, medtech and health technology sector. Co-signatory on joint letters to Treasurer Jim Chalmers alongside seven other peak bodies.
  • AusBiotech, BioNSW, Life Sciences Queensland, Life Sciences WA, Pathology Technology Australia, MTPConnect, ANDHealth, ARCS AustraliacoreStrategic or Co-development PartnerNine peak health and medical technology industry bodies united in opposition to proposed R&D Tax Incentive changes and capital gains tax reforms, sending joint letter to Treasurer Jim Chalmers.
  • Victorian Government (Department of Jobs, Skills, Industry and Regions)coreStrategic or Co-development PartnerKey government partner supporting BioMelbourne Network initiatives including BioSymposiums as Premier Sponsor, establishment grant in 2002, and ongoing sector development programs.
  • RMIT UniversitymajorStrategic or Co-development PartnerMajor sponsor of BioSymposium 'Next-gen Biosensing' and collaborator on biosensing research translation initiatives.
  • FB RicemajorGTM or Marketing PartnerMajor sponsor of BioSymposium 'Next-gen Biosensing'. Intellectual property consultancy supporting the health technology ecosystem.
  • SeerPharmasupportingGTM or Marketing PartnerSupporting sponsor of BioSymposium 'Next-gen Biosensing' and contributor to regulatory and clinical trials discussions.
  • IQVIA BiotechcoreGTM or Marketing PartnerThought Leader Partner for BioSymposium 'Modernising clinical trials', bringing expertise in clinical trial design and execution.
  • PureCDMmajorGTM or Marketing PartnerMajor Sponsor for 'Modernising clinical trials' BioSymposium, supporting decentralised clinical trial discussions.
  • Chubb Insurance AustraliasupportingGTM or Marketing PartnerSupporting sponsor for clinical trials BioSymposium, providing insurance expertise for clinical research sector.
  • CSL BehringmajorGTM or Marketing PartnerMajor sponsor of the 2026 Connecting Women Lunch. CSL has been a longstanding supporter of the event with video presentations.
  • Global VictoriacoreStrategic or Co-development PartnerGovernment partner for trade missions to Singapore 2022, connecting Victorian health and medtech companies with international markets.
  • Invest VictoriacoreStrategic or Co-development PartnerPartner for Singapore trade mission, providing networking events and investment facilitation for Victorian companies.
  • Jumpstart, Medtech Innovator, A*StarminorChannel Partner/ Reseller/ DistributorInternational medtech accelerators and government partners collaborating on Singapore trade mission program.
  • WilamcoreStrategic or Co-development PartnerOnline health technologies platform operated by BioMelbourne Network serving 7,000+ professionals with networking and resource capabilities.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

BioMelbourne Network competitors and assessment

Company assessment

Direct peers

  • ANDHealth:
  • Pathology Technology Australia: Australian industry body representing the in-vitro diagnostics and pathology technology sector. Directly comparable as a membership-based industry association representing health technology manufacturers and service providers, and a joint advocacy partner on R&D Tax Incentive issues.
  • MTPConnect: Australian Government-funded MedTech and Pharma Growth Centre, operating as an industry connector for the sector. Directly comparable as a peak body driving collaboration, events, and policy advocacy across Australia's medical technology and pharmaceutical sectors, and a co-signatory with BioMelbourne on national policy submissions.
  • ARCS Australia: Australia's peak industry body for the clinical research, pharmaceutical, and medical device sectors. Directly comparable as a membership association providing professional development, advocacy, and sector events for organisations across the health technology value chain, and a fellow co-signatory on BioMelbourne's policy submissions.
  • AusBiotech: Australia's national biotechnology industry association. Directly comparable as a membership-based industry body serving biotech, medtech, and health tech companies across Australia, and BioMelbourne's principal co-advocacy partner on R&D Tax Incentive issues.

Regional players

  • MedCity: London-based life sciences cluster organisation supporting health technology and medtech companies in the greater London region. Comparable as a cluster-based industry body with a similar mission of connecting companies, research, and capital in a defined geographic health tech ecosystem, but operating in a different geography.
  • Life Sciences WA: Western Australia's peak industry body for the life sciences sector. Comparable to BioMelbourne Network as a state-level Australian membership association for health technologies, but operating in a different geography (WA) and not directly competing for Victorian members.
  • Life Sciences Queensland: Queensland's peak industry body for life sciences and health technologies. Closely comparable to BioMelbourne Network as a state-level membership association, but operating in a different Australian state and therefore not in direct competition for Victorian members.
  • BioNSW: New South Wales' industry association for the biotechnology and life sciences sector. Comparable as a state-level Australian membership body serving biotech and health tech organisations, but focused on NSW-based members and therefore a regional rather than direct competitor.

Broad incumbents

  • MassBio: Massachusetts' state-level biotechnology industry association, one of the largest and most established US life sciences industry bodies. Comparable as a broader incumbent offering a more comprehensive suite of member services, policy advocacy, and events, and serving as a benchmark model for the kind of regional life sciences association BioMelbourne aspires to be.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

BioMelbourne Network social profiles

Digital presence

BioMelbourne Network financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BioMelbourne Network leadership team

Management profile

Number of profiles

Profiles4 records

BioMelbourne Network funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BioMelbourne Network M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioMelbourne Network

What does BioMelbourne Network do?

BioMelbourne Network is a not-for-profit, industry-led membership association that connects biotechnology, medical technology, and health innovation organisations in Victoria, Australia. It sells tiered annual memberships and delivers networking events, advocacy, and online community platforms (Wilam, BioResource Hub, Careers Hub) that foster collaboration, commercialisation, and policy engagement across the state's health technology ecosystem.

Is BioMelbourne Network a public or private company?

BioMelbourne Network is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was BioMelbourne Network founded?

BioMelbourne Network was founded in 2001. It employs 11 to 50 people.

Where is BioMelbourne Network based?

BioMelbourne Network is headquartered in Melbourne, Australia, in the Oceania region.

How does BioMelbourne Network make money?

Three revenue lines are on record. Membership Fees are the primary driver. The others are event Registration Fees and event Sponsorship.

Who are BioMelbourne Network's main competitors?

Direct peers on record are ANDHealth, Pathology Technology Australia, MTPConnect, ARCS Australia and AusBiotech. Regional players are MedCity, Life Sciences WA, Life Sciences Queensland and BioNSW. MassBio is listed as a broad incumbent.

Does BioMelbourne Network have an API?

No public API is recorded for BioMelbourne Network.

What industry is BioMelbourne Network in?

BioMelbourne Network's product category is Health Technology Industry Association. Its primary akta.pro industry code is THAHAJAB, Life Sciences & Biotechnology Congresses. Its NAICS code is 813 and its SIC code is 8600.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ABCMedical technology sector raises fresh concerns with Labor’s capital gains tax overhaulNine peak health and medical technology industry bodies in Australia, including Bio NSW, Life Sciences Queensland, BioMelbourne Network, Life Sciences WA, and AusBiotech, have sent a joint letter to Treasurer Jim Chalmers opposing Labor's tax policy changes, warning that a ten-year limit on refundable R&D tax incentives combined with capital gains tax reforms pose a "triple threat" to the sector. The groups argue that medical technology companies typically take 17 years to bring products to market, making the ten-year cap on refunds particularly damaging for startups that operate at a loss during early development phases. The bill has passed the lower house and is subject to a two-day Senate inquiry before potential passage, with industry bodies urging the government to adjust the policy settings to provide certainty for Australian biotech and medtech companies.BiomelbourneBioForum – Bispecific Antibodies / AXC: Development, Manufacturing and Regulatory PathwaysBioMelbourne Network, in collaboration with ProBio and hosted by Davies Collison Cave, is organizing a hybrid BioForum to discuss the development, manufacturing, and regulatory pathways for bispecific antibodies and antibody-X conjugates. The event aims to provide practical insights into design, manufacturability, and scalability while addressing challenges in translating these therapeutics from preclinical to commercial stages.PR Newswire APACProta Therapeutics' CEO Mimi Tang honoured at BioMelbourne Network's Women in Leadership Awards 2024Prota Therapeutics CEO Professor Mimi Tang received the Distinguished Leadership Award at the 2024 BioMelbourne Network Women in Leadership Awards for her contributions to food allergy research. Her work includes leading the development of novel immunotherapies, notably securing US$21 million for a Phase 3 clinical trial of the PRT120 oral therapy for peanut allergy. Additionally, she is recognized for creating the AllergyPal mobile app and her extensive academic record in immunology.